In re Brand Name Prescription Drugs Antitrust Litigation
United States Court of Appeals for the Seventh Circuit
288 F.3d 1028 (2002)

- Written by Mary Phelan D'Isa, JD
Facts
Retail sellers of prescription drugs (retail pharmacies) (plaintiffs) alleged that brand-name prescription drug manufacturers and wholesalers (defendants) violated the Sherman Act, a federal antitrust law, by conspiring in a discriminatory pricing scheme to charge hospitals and retail pharmacies different prices. The retail pharmacies alleged that the manufacturers agreed not to give the retail pharmacies discounts by enlisting wholesalers to police the agreement by means of a chargeback system that the retail pharmacies alleged resulted in denying them discounts they would have received but for the conspiracy. The district court granted the wholesalers’ motion to dismiss, and the retail pharmacies appealed. The manufacturers were not part of the appeal.
Rule of Law
Issue
Holding and Reasoning (Posner, J.)
What to do next…
Here's why 834,000 law students have relied on our case briefs:
- Written by law professors and practitioners, not other law students. 46,600 briefs, keyed to 994 casebooks. Top-notch customer support.
- The right amount of information, includes the facts, issues, rule of law, holding and reasoning, and any concurrences and dissents.
- Access in your classes, works on your mobile and tablet. Massive library of related video lessons and high quality multiple-choice questions.
- Easy to use, uniform format for every case brief. Written in plain English, not in legalese. Our briefs summarize and simplify; they don’t just repeat the court’s language.